Future Pahrma

Ghaziabad, India Founded: 2015 • Age: 11 yrs
Pharmaceutical products are manufactured and distributed by Future Pharma, focusing on global standards and affordability.

About Future Pahrma

Future Pahrma is a Healthcare company based in Ghaziabad (India) founded in 2015. Pharmaceutical products are manufactured and distributed by Future Pharma, focusing on global standards and affordability. The company has 273 employees. Its Indian entity Future Pharma Private Limited reported revenue of β‚Ή9.22 Cr. Future Pahrma offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medicine Production and Personal Care.

Company details

Pharmaceuticals are manufactured and marketed by Future Pharma Pvt. Ltd. to meet global standards while ensuring affordability, with a wide array of products including tablets, capsules, injectables, infusions, syrups, ointments, creams, soaps, and shampoos being offered. The company emphasizes customer satisfaction and provides services aimed at promoting health and wellness. Products are distributed through various channels, and the entity is located in Ghaziabad, India, where efforts are made to maintain quality and integrity in operations. Contact options are provided for inquiries, reflecting a commitment to accessibility in the industry.

  • Headquarters Ghaziabad, India
  • Employees 273
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website futurepharma.co.in
  • Social LinkedIn Facebook
  • Legal Name Future Pharma Pvt. Ltd
  • Date of Incorporation 27 Feb, 2009
  • Jurisdiction Kanpur, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹9.22 Cr

    FY 2025 · +17% YoY

  • Net Profit
    ₹11.8 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹13.8 Lakh

    FY 2025 · 1% margin

  • Employee Count
    273

Products & Services of Future Pahrma

Future Pahrma offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceuticals

Tablets are manufactured as part of a wide selection of pharmaceutical products that address various health requirements.

Capsules
Pharmaceuticals

Capsules are produced alongside other items like injectables and ointments to support health and wellness needs.

Board of directors of Future Pharma Private Limited (Future Pahrma)

Future Pharma Private Limited is the primary company behind Future Pahrma. The board of Future Pharma Private Limited currently have 3 directors; the longest-serving is Krishan Gopal Gupta, appointed in 2009.

DirectorDesignationAppointedTenureEntity
Krishan Gopal Gupta
DIN 02521233
Director27 Feb 200917 yrs 8 moFuture Pharma Private Limited
Lokesh Gupta
DIN 02521364
Director27 Feb 200917 yrs 8 moFuture Pharma Private Limited
Manoj Kumar Gupta
DIN 02521309
Director27 Feb 200917 yrs 8 moFuture Pharma Private Limited

Financials of Future Pahrma

Figures of Future Pharma Private Limited, the primary company behind Future Pahrma, for FY 2025. Revenue was ₹9.22 Cr (+17% year on year). Net profit was ₹11.8 Lakh (1% margin). EBITDA was ₹13.8 Lakh (1% margin). Revenue has grown at a compounded annual rate of +23% over three years and -26% over five years.

  • ₹9.22 CrRevenue · FY 2025 · +17% YoY
  • ₹11.8 LakhNet profit · 1% margin
  • ₹13.8 LakhEBITDA · 1% margin
  • ₹1 LakhPaid-up capital
  • 273Employees (provident fund records)
  • +23%Revenue CAGR, 3 years
  • -26%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Future Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Future Pahrma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Future Pahrma

Future Pahrma was founded in 2015.

Future Pahrma is headquartered in Ghaziabad, India. It is registered at Ghaziabad, Uttar Pradesh, India.

Future Pahrma has 273 employees.

The primary company behind Future Pahrma, Future Pharma Private Limited, reported revenue of β‚Ή9.22 Cr for FY 2025, up 17% year on year.

Pharmaceuticals are manufactured and marketed by Future Pharma Pvt. Ltd. to meet global standards while ensuring affordability, with a wide array of products including tablets, capsules, injectables, infusions, syrups, ointments, creams, soaps, and shampoos being offered. The company emphasizes customer satisfaction and provides services aimed at promoting health and wellness. Products are distributed through various channels, and the entity is located in Ghaziabad, India, where efforts are made to maintain quality and integrity in operations. Contact options are provided for inquiries, reflecting a commitment to accessibility in the industry.

Future Pahrma offers Tablets and Capsules.

Future Pahrma operates through Future Pharma Private Limited.

The legal entities of Future Pahrma currently have 3 directors, including Krishan Gopal Gupta, Lokesh Gupta, Manoj Kumar Gupta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available